These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The role of N-glycosylation in cell fusion induced by a vaccinia recombinant virus expressing both measles virus glycoproteins. Malvoisin E; Wild F Virology; 1994 Apr; 200(1):11-20. PubMed ID: 8128615 [TBL] [Abstract][Full Text] [Related]
23. Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999. Bauer K; Schrader C; Suess J; Wutzler P; Schmidtke M Antiviral Res; 2007 Sep; 75(3):219-26. PubMed ID: 17445913 [TBL] [Abstract][Full Text] [Related]
24. Influenza A surface glycosylation and vaccine design. Wu CY; Lin CW; Tsai TI; Lee CD; Chuang HY; Chen JB; Tsai MH; Chen BR; Lo PW; Liu CP; Shivatare VS; Wong CH Proc Natl Acad Sci U S A; 2017 Jan; 114(2):280-285. PubMed ID: 28028222 [TBL] [Abstract][Full Text] [Related]
25. Biological and protective properties of immune sera directed to the influenza virus neuraminidase. Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225 [TBL] [Abstract][Full Text] [Related]
26. Manipulation of the biosynthesis of protein-modifying glycoconjugates by the use of specific inhibitors. Schwarz RT Behring Inst Mitt; 1991 Jul; (89):198-208. PubMed ID: 1834053 [TBL] [Abstract][Full Text] [Related]
27. Immunoelectron microscopy of influenza A virus neuraminidase glycoprotein topography. Amano H; Uemoto H; Kuroda K; Hosaka Y J Gen Virol; 1992 Aug; 73 ( Pt 8)():1969-75. PubMed ID: 1645138 [TBL] [Abstract][Full Text] [Related]
28. M protein correlates with the receptor-binding specificity of haemagglutinin protein of reassortant influenza A (H1N1) virus. Tong N; Nobusawa E; Morishita M; Nakajima S; Nakajima K J Gen Virol; 1998 Oct; 79 ( Pt 10)():2425-34. PubMed ID: 9780048 [TBL] [Abstract][Full Text] [Related]
29. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. Lu B; Zhou H; Ye D; Kemble G; Jin H J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915 [TBL] [Abstract][Full Text] [Related]
30. Influence of N-glycosylation and N-glycan trimming on the activity and intracellular traffic of GD3 synthase. Martina JA; Daniotti JL; Maccioni HJ J Biol Chem; 1998 Feb; 273(6):3725-31. PubMed ID: 9452504 [TBL] [Abstract][Full Text] [Related]
31. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. Jin H; Leser GP; Zhang J; Lamb RA EMBO J; 1997 Mar; 16(6):1236-47. PubMed ID: 9135140 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo. Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971 [TBL] [Abstract][Full Text] [Related]
33. Glycosylation Characterization of an Influenza H5N7 Hemagglutinin Series with Engineered Glycosylation Patterns: Implications for Structure-Function Relationships. Parsons LM; An Y; de Vries RP; de Haan CA; Cipollo JF J Proteome Res; 2017 Feb; 16(2):398-412. PubMed ID: 28060516 [TBL] [Abstract][Full Text] [Related]
34. Charged amino acid variability related to N-glyco -sylation and epitopes in A/H3N2 influenza: Hem -agglutinin and neuraminidase. Huang ZZ; Yu L; Huang P; Liang LJ; Guo Q PLoS One; 2017; 12(7):e0178231. PubMed ID: 28708860 [TBL] [Abstract][Full Text] [Related]
35. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs. Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559 [TBL] [Abstract][Full Text] [Related]
36. Screening for Neuraminidase Inhibitor Resistance Markers among Avian Influenza Viruses of the N4, N5, N6, and N8 Neuraminidase Subtypes. Choi WS; Jeong JH; Kwon JJ; Ahn SJ; Lloren KKS; Kwon HI; Chae HB; Hwang J; Kim MH; Kim CJ; Webby RJ; Govorkova EA; Choi YK; Baek YH; Song MS J Virol; 2018 Jan; 92(1):. PubMed ID: 29046464 [TBL] [Abstract][Full Text] [Related]
37. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice. Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088 [TBL] [Abstract][Full Text] [Related]
38. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Johansson BE; Kilbourne ED Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540 [TBL] [Abstract][Full Text] [Related]
39. Hemagglutinin specificity and neuraminidase coding capacity of neuraminidase-deficient influenza viruses. Yang P; Bansal A; Liu C; Air GM Virology; 1997 Mar; 229(1):155-65. PubMed ID: 9123857 [TBL] [Abstract][Full Text] [Related]
40. The effects of oligosaccharide trimming inhibitors on glycoprotein expression and infectivity of Junin virus. Silber AM; Candurra NA; Damonte EB FEMS Microbiol Lett; 1993 May; 109(1):39-43. PubMed ID: 8391500 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]